SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    B. Eksteen, Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis, British Medical Bulletin, 2014, 110, 1, 89

    CrossRef

  2. 2
    Ahmad H Ali, Elizabeth J Carey, Keith D Lindor, An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis, Expert Opinion on Orphan Drugs, 2014, 2, 6, 545

    CrossRef

  3. 3
    Kidist K. Yimam, Christopher L. Bowlus, Diagnosis and classification of primary sclerosing cholangitis, Autoimmunity Reviews, 2014, 13, 4-5, 445

    CrossRef

  4. 4
    Andres J. Yarur, Frank Czul, Cynthia Levy, Hepatobiliary Manifestations of Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 2014, 20, 9, 1655

    CrossRef

  5. 5
    U. Navaneethan, Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk, Gastroenterology Report, 2014, 2, 3, 193

    CrossRef

  6. 6
    James H. Tabibian, Steven P. O’Hara, Keith D. Lindor, Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies, Scandinavian Journal of Gastroenterology, 2014, 49, 8, 901

    CrossRef

  7. 7
    Hanh D. Vo, Jiliu Xu, Simon S. Rabinowitz, Stanley E. Fisher, Steven M. Schwarz, The Liver in Pediatric Gastrointestinal Disease, Journal of Pediatric Gastroenterology and Nutrition, 2014, 59, 3, 288

    CrossRef

  8. 8
    Janosch Katt, Dorothee Schwinge, Tanja Schoknecht, Alexander Quaas, Ingo Sobottka, Eike Burandt, Christoph Becker, Markus F. Neurath, Ansgar W. Lohse, Johannes Herkel, Christoph Schramm, Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis, Hepatology, 2013, 58, 3
  9. 9
    John E. Eaton, Jayant A. Talwalkar, Konstantinos N. Lazaridis, Gregory J. Gores, Keith D. Lindor, Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management, Gastroenterology, 2013, 145, 3, 521

    CrossRef

  10. 10
    Gideon M Hirschfield, Tom H Karlsen, Keith D Lindor, David H Adams, Primary sclerosing cholangitis, The Lancet, 2013, 382, 9904, 1587

    CrossRef

  11. 11
    James H Tabibian, Keith D Lindor, Primary sclerosing cholangitis: a review and update on therapeutic developments, Expert Review of Gastroenterology & Hepatology, 2013, 7, 2, 103

    CrossRef

  12. You have free access to this content12
    J. H. Tabibian, E. Weeding, R. A. Jorgensen, J. L. Petz, J. C. Keach, J. A. Talwalkar, K. D. Lindor, Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study, Alimentary Pharmacology & Therapeutics, 2013, 37, 6
  13. 13
    James H. Tabibian, Jayant A. Talwalkar, Keith D. Lindor, Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis, BioMed Research International, 2013, 2013, 1

    CrossRef

  14. 14
    M.M. Wells, K.P. Croome, E. Boyce, N. Chandok, Roux-en-Y Choledochojejunostomy Versus Duct-to-Duct Biliary Anastomosis in Liver Transplantation for Primary Sclerosing Cholangitis: A Meta-Analysis, Transplantation Proceedings, 2013, 45, 6, 2263

    CrossRef

  15. 15
    Tom H. Karlsen, Kirsten Muri Boberg, Update on primary sclerosing cholangitis, Journal of Hepatology, 2013, 59, 3, 571

    CrossRef

  16. 16
    Elizabeth J Carey, Keith D Lindor, Current pharmacotherapy for cholestatic liver disease, Expert Opinion on Pharmacotherapy, 2012, 13, 17, 2473

    CrossRef

  17. 17
    Ashley Barnabas, Roger W. Chapman, Primary Sclerosing Cholangitis: Is Any Treatment Worthwhile?, Current Gastroenterology Reports, 2012, 14, 1, 17

    CrossRef

  18. 18
    Mohamad H Imam, Keith D Lindor, Primary sclerosing cholangitis: providing a safe and effective treatment, Expert Review of Gastroenterology & Hepatology, 2012, 6, 3, 255

    CrossRef

  19. 19
    Mohamed O. Othman, Jeffery Dunkelberg, Praveen K. Roy, Urosdeoxycholic acid in primary sclerosing cholangitis: A meta-analysis and systematic review, Arab Journal of Gastroenterology, 2012, 13, 3, 103

    CrossRef

  20. 20
    Diaa Aldin H Elfaki, Keith D Lindor, Antibiotics for the Treatment of Primary Sclerosing Cholangitis, American Journal of Therapeutics, 2011, 18, 3, 261

    CrossRef

  21. 21
    Albert Parés, Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento, Gastroenterología y Hepatología, 2011, 34, 1, 41

    CrossRef

  22. 22
    Samar H. Ibrahim, Keith D. Lindor, Current Management of Primary Sclerosing Cholangitis in Pediatric Patients, Pediatric Drugs, 2011, 13, 2, 87

    CrossRef

  23. 23
    Tobias J. Weismüller, Tim O. Lankisch, Medical and endoscopic therapy of primary sclerosing cholangitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 741

    CrossRef

  24. 24
    Keith D. Lindor, New Treatment Strategies for Primary Sclerosing Cholangitis, Digestive Diseases, 2011, 29, 1, 113

    CrossRef

  25. 25
    Marion J. Pollheimer, Emina Halilbasic, Peter Fickert, Michael Trauner, Pathogenesis of primary sclerosing cholangitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 727

    CrossRef

  26. 26
    E. L. Culver, R. W. Chapman, Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4-associated cholangitis and overlap with autoimmune hepatitis, Alimentary Pharmacology & Therapeutics, 2011, 33, 12
  27. 27
    Daniel Gotthardt, Adolf Stiehl, Endoscopic Retrograde Cholangiopancreatography in Diagnosis and Treatment of Primary Sclerosing Cholangitis, Clinics in Liver Disease, 2010, 14, 2, 349

    CrossRef

  28. 28
    Claudia O. Zein, Keith D. Lindor, Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis, Current Gastroenterology Reports, 2010, 12, 1, 13

    CrossRef

  29. 29
    Emmanouil Sinakos, Keith Lindor, Treatment options for primary sclerosing cholangitis, Expert Review of Gastroenterology & Hepatology, 2010, 4, 4, 473

    CrossRef

  30. 30
    Tom H. Karlsen, Erik Schrumpf, Kirsten M. Boberg, Update on primary sclerosing cholangitis, Digestive and Liver Disease, 2010, 42, 6, 390

    CrossRef

  31. 31
    Crystal Knight, Karen F Murray, Hepatobiliary associations with inflammatory bowel disease, Expert Review of Gastroenterology & Hepatology, 2009, 3, 6, 681

    CrossRef

  32. 32
    Marina G Silveira, Natalie J Torok, Andrea A Gossard, Jill C Keach, Roberta A Jorgensen, RN, Janice L Petz, RN, Keith D Lindor, Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study, The American Journal of Gastroenterology, 2009, 104, 1, 83

    CrossRef

  33. 33
    Jens J. W. Tischendorf, Andreas Geier, Christian Trautwein, Current diagnosis and management of primary sclerosing cholangitis, Liver Transplantation, 2008, 14, 6
  34. 34
    Gustav Paumgartner, Thomas Pusl, Medical Treatment of Cholestatic Liver Disease, Clinics in Liver Disease, 2008, 12, 1, 53

    CrossRef

  35. 35
    Timothy Smith, Alex S. Befeler, High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis, Current Gastroenterology Reports, 2007, 9, 1, 54

    CrossRef

  36. 36
    Peter B Soeters, Misha D Luyer, Jan Willem M Greve, Wim A Buurman, The significance of bowel permeability, Current Opinion in Clinical Nutrition and Metabolic Care, 2007, 10, 5, 632

    CrossRef

  37. 37
    Daniel Rost, Hasan Kulaksiz, Adolf Stiehl, Treatment of primary sclerosing cholangitis, Current Treatment Options in Gastroenterology, 2007, 10, 2, 111

    CrossRef

  38. 38
    S. Dar, H.R. Dalton, 2007,

    CrossRef

  39. 39
    Phunchai Charatcharoenwitthaya, Keith D. Lindor, Primary sclerosing cholangitis: Diagnosis and management, Current Gastroenterology Reports, 2006, 8, 1, 75

    CrossRef

  40. 40
    Nicholas F. LaRusso, Benjamin L. Shneider, Dennis Black, Gregory J. Gores, Stephen P. James, Edward Doo, Jay H. Hoofnagle, Primary sclerosing cholangitis: Summary of a workshop, Hepatology, 2006, 44, 3
  41. 41
    George R MacFaul, Roger W Chapman, Sclerosing cholangitis, Current Opinion in Gastroenterology, 2006, 22, 3, 288

    CrossRef

  42. 42
    Rolf Olsson, Kirsten M. Boberg, Ove Schaffalitsky de Muckadell, Stefan Lindgren, Rolf Hultcrantz, Geir Folvik, Helge Bell, Magnhild Gangsøy–Kristiansen, Jon Matre, Andreas Rydning, Ola Wikman, Åke Danielsson, Hanna Sandberg–Gertzén, Kjell–Arne Ung, Anders Eriksson, Lars Lööf, Hanne Prytz, Hanns–Ulrich Marschall, Ulrika Broomé, High-Dose Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: A 5-Year Multicenter, Randomized, Controlled Study, Gastroenterology, 2005, 129, 5, 1464

    CrossRef